Department of Biochemistry, University of Zimbabwe, Mt. Pleasant, Harare, Zimbabwe.
Department of Chemistry, University of Zimbabwe, Mt. Pleasant, Harare, Zimbabwe.
Biomed Res Int. 2020 Oct 5;2020:1263702. doi: 10.1155/2020/1263702. eCollection 2020.
Plants are a source of over a quarter of the prescription drugs currently in use worldwide. Zimbabwe has a rich plant biodiversity with only a limited number reported for the treatment of cancer. The leaf extracts of were selected for the screening of their antiproliferative efficacy and cytotoxicity effects. This plant has increasingly been used by local folk as a treatment for cancer or cancer-related symptoms though its bioactivity has not been scientifically determined. This investigation also sought to identify constituent compounds in the crude extract preparations responsible for their antiproliferative efficacy. The antiproliferative effects of six-leaf extracts on Jurkat-T were investigated using the Trypan blue exclusion assay. The extracts were tested with increasing concentration, using chlorambucil as a standard anticancer drug. Cytotoxicity of extracts was determined against RAW 264.7 cells using a colorimetric tetrazolium-based assay. In additionthe ability of the extracts to induce apoptosis was determined for the most potent leaf extracts. The order of potency of the leaf extracts of against Jurkat-T cell line was found to be MeOH < Ethyl Acetate < DCM: MeOH < EtOH with ICs of 33.56, 30.44, 22.93, and 21.59 g/mL, respectively. Furthermore, the most potent extracts exhibited very low cytotoxicity against all the tested cells. leaf extracts induced apoptosis in the Jurkat-T cells as was shown by DNA fragmentation. UPLC-MS analysis of crude extracts led to the identification of 23 compounds from the ethanol extract and these may be responsible for the observed antiproliferative effects. Rutin, quercetin, luteolin, apigenin, hispidulin, kaempferol derivatives, as well as caffeoylquinic acid are some of the compounds identified in the extracts. The results of this study showed that the ethanol and ethyl acetate leaf extracts of have antiproliferative activity against Jurkat-T cells and may act by inducing apoptosis.. The current findings offer supporting evidence for the use of these plant species in the treatment of cancer in ethnomedicinal practices.
植物是目前全球使用的四分之一以上处方药的来源。津巴布韦拥有丰富的植物生物多样性,但仅有少数几种被报道可用于治疗癌症。因此选择 的叶子提取物进行抗增殖功效和细胞毒性作用的筛选。尽管其生物活性尚未得到科学确定,但这种植物已被当地民间用作治疗癌症或与癌症相关症状的方法。这项研究还旨在确定负责其抗增殖功效的粗提物制剂中的成分化合物。使用台盼蓝排除试验研究了六种叶子提取物对 Jurkat-T 细胞的抗增殖作用。使用氯氨嘧啶作为标准抗癌药物,用增加浓度的方法测试提取物。使用基于比色四唑的测定法测定提取物对 RAW 264.7 细胞的细胞毒性。此外,还确定了最有效叶子提取物诱导细胞凋亡的能力。发现 的叶子提取物对 Jurkat-T 细胞系的效力顺序为 MeOH < Ethyl Acetate < DCM: MeOH < EtOH,IC 分别为 33.56、30.44、22.93 和 21.59μg/ml。此外,最有效的提取物对所有测试细胞的细胞毒性都非常低。UPLC-MS 分析粗提物导致从乙醇提取物中鉴定出 23 种化合物,这些化合物可能是观察到的抗增殖作用的原因。在提取物中鉴定出的化合物包括芦丁、槲皮素、木犀草素、芹菜素、异甘草素、山奈酚衍生物以及咖啡酰奎宁酸。这项研究的结果表明, 的乙醇和乙酸乙酯叶提取物对 Jurkat-T 细胞具有抗增殖活性,并且可能通过诱导细胞凋亡起作用。目前的研究结果为这些植物物种在民族医学实践中用于癌症治疗提供了支持证据。